Back to results
UnknownPhase 2

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

NCT02025712

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Unimed Medical Institute

Hong Kong, China

Contact

Louis Chow, MD

(852)28610286
View on ClinicalTrials.gov